A. Rachel Leheny - Nov 6, 2023 Form 4 Insider Report for CalciMedica, Inc. (CALC)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
By John Dunn, Attorney-in-Fact
Stock symbol
CALC
Transactions as of
Nov 6, 2023
Transactions value $
$7,615
Form type
4
Date filed
11/7/2023, 06:09 PM
Previous filing
Nov 6, 2023
Next filing
Nov 8, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CALC Common Stock Purchase $7.61K +2.44K +16.94% $3.12 16.8K Nov 6, 2023 Direct F1
holding CALC Common Stock 1K Nov 6, 2023 By Spouse
holding CALC Common Stock 357K Nov 6, 2023 By Valence Investments SPV IV, LLC F2
holding CALC Common Stock 66.2K Nov 6, 2023 By Valence Investments SPV V, LLC F2
holding CALC Common Stock 316K Nov 6, 2023 By Valence Investments SPV VI, LLC F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The weighted average purchase price for the transaction reported was $3.1208, and the range of prices were between $3.11 and $3.17. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
F2 The Reporting Person, a co-founder and managing director of Valence Investments SPV IV, LLC ("Valence IV"), Valence Investments SPV V, LLC ("Valence V") and Valence Investments SPV VI, LLC (Valence VI), may be deemed to beneficially own the securities held by Valence IV, Valence V and Valence VI (the "Valence Securities"). The Reporting Person disclaims beneficial ownership of the Valence Securities except to the extent of her pecuniary interest therein.